Chemed Corp. (CHE)
NYSEHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
$519.84-0.88%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
QuarterlyIQ Insights · CHE
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 13.5% |
| Our one-year growth estimate | diamond | 8.3% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 5.2 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 26 industry peers
CHE — credit agreement
Dated 2026-04-13
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT On April 10, 2026, Chemed Corporation (“Chemed” or "we") renewed our $450 million senior secured credit facilities (“Credit Facilities”). JPMorgan Chase Bank, N.A., acted as the Administrative Agent, Joint Lead Arranger and Joint Bookrunner. Bank of America, N.A., acted as Joint Lead Arranger, Joint Bookrunner and Syndication Agent. PNC Bank, N.A. and U.S. Bank, N.A. were Co-Documentation Agents. Terms of the Credit Facilities consist of a five-year…
Why it matters: Ongoing share buybacks can raise shareholder value. They also show management's trust.
Supportive ifManagement says the share buyback program will continue at $100 million.
Worry ifNo further share repurchases announced in the next quarter.
Why it matters: Ongoing share buybacks can help stock price. They show management wants to give value to shareholders.
Supportive ifChemed repurchases shares at a similar rate as in Q2 2026.
Worry ifShare repurchases slow significantly or stop in Q3 2026.
Why it matters: Higher EPS guidance shows strong performance. This can help investor feelings.
Supportive ifManagement raises full-year EPS guidance to more than $25.75.
Worry ifEPS guidance remains at or below $25.00.
Why it matters: Higher EPS guidance shows strong performance. It shows management believes in future earnings.
Supportive ifEPS guidance is raised above $25.75 for full-year 2026.
Worry ifEPS guidance remains at or below $25.75 for full-year 2026.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$81 on $10,000 · ±0.8% | How much price usually moves either way. |
| Bad day | $248 loss on $10,000 · 2.5% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,298 loss on $10,000 · 23.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: If Roto-Rooter meets its revenue growth goal, it shows good management of challenges.
Watch forRoto-Rooter revenue growth meets or exceeds the guidance of 3.0% to 3.5%.
Also watch forRoto-Rooter revenue growth falls below 3.0%.
Why it matters: Using over $100 million shows strong trust in the company’s finances.
Supportive ifShare repurchase use exceeds $100 million.
Worry ifShare repurchase use stays below $50 million.
Why it matters: Share buybacks can show management's confidence and help share price.
Supportive ifManagement announces more share buybacks in Q3.
Worry ifNo share repurchases announced in Q3.
Why it matters: Strong VITAS growth shows recovery from past Medicare Cap problems. It also boosts earnings.
Supportive ifVITAS revenue growth exceeds 12% year over year in Q3.
Worry ifVITAS revenue growth falls below 10% year over year in Q3.